Elsevier

Clinical Radiology

Volume 49, Issue 2, February 1994, Pages 123-125
Clinical Radiology

Reasons underlying negative mammography in patients with palpable breast cancer

https://doi.org/10.1016/S0009-9260(05)83454-3Get rights and content

It is well recognized that a negative mammogram report does not exclude the presence of breast carcinoma. This study examines the accuracy of mammography in patients with palpable breast cancer. In particular, the study evaluates the reasons underlying negative mammography in breast cancer. All patients with Pagets' disease, carcinoma in situ lesions or lesions infiltrating skin were excluded. A total of 291 patients presenting with palpable breast carcinoma underwent mammography prior to biopsy. False negative reports occurred in 16.5% (48). The sensitivity of mammography increased with age, from 70% (14/20) in 31–40-year-olds to 91% (113/124) in women over 60 years. Retrospective review of false negative mammograms showed that 30% of these were deemed normal while 20% were obvious oversights. The remaining 50% showed subtle radiographic abnormalities, consistent with but not diagnostic of malignancy.

References (19)

There are more references available in the full text version of this article.

Cited by (55)

  • Impact of the Addition of Digital Breast Tomosynthesis (DBT) to Standard 2D Digital Screening Mammography on the Rates of Patient Recall, Cancer Detection, and Recommendations for Short-term Follow-up

    2017, Academic Radiology
    Citation Excerpt :

    However, it is an imperfect technology and there are concerns regarding false-positive results and sensitivity, particularly in dense breasts. Estimated positive predictive values (PPVs) for screening mammography average 5% (range 4.4%–16.8%) (8), and false-negative rates for symptomatic women range from 8% to 66% depending on breast density and tumor type (9–14). It is thought that the large variability in interpretation performance between radiologists is partly owing to overlapping tissue (15–20), and superior sensitivity in fatty breasts is attributed to the ability to see lesion margins better, a key factor in distinguishing benign from malignant lesions (21).

  • Exploring a non-inflammatory clinical breast mass: Clinical practice guidelines

    2015, Journal de Gynecologie Obstetrique et Biologie de la Reproduction
  • Screening and Diagnosis of Breast Cancer in Low-Resource Countries: What Is State of the Art?

    2011, Seminars in Ultrasound, CT and MRI
    Citation Excerpt :

    Mammography has limitations in the evaluation of the symptomatic woman, particularly in those with dense breasts. A false-negative rate as high as 16.5% has been reported for mammography in patients with a palpable breast abnormality.23 Mammographic abnormalities identified in a symptomatic woman usually require additional diagnostic ultrasound work-up, and in those with a suspicious palpable solid mass seen on a mammogram and a sonogram, the latter is a better modality for tissue sampling.

View all citing articles on Scopus
View full text